AbbVie (ABBV) Plans $7.5B Tender Offer

With earnings, AbbVie (NYSE: ABBV) said it plans to commence a tender offer to purchase for cash up to $7.5 billion in value of shares of its common stock through a modified "Dutch auction" tender offer at a specified price range to be determined. AbbVie expects to commence the tender offer as early as May 1, 2018.

The tender offer forms a part of AbbVie's $10 billion stock repurchase program announced on February 15, 2018.

You May Also Be Interested In

• Abbvie (ABBV) PT Raised to $273 at Canaccord
• Abbvie (ABBV) Reiterated at Overweight by Cantor Fitzgerald after Analyst Call
• Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE) in Canada, the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patie